Summary
Introduction
A sensitive procedure for predicting effectiveness of chemotherapeutic drugs in cancer patients before initiation of therapy could provide enhanced therapeutic benefit. Many methods have been designed to establish tumour-specific drug sensitivity, and a number of reports concerning the Correspondence: Dr Rudolf Kuzmits, 11. Department of Medicine, Gamisongasse 13, A-1090 Vienna, Austria. prediction of anti-cancer drug effects have been published. Agar cloning assays [I] , dye exclusion tests [2, 31 , labelling index methods [4] and changes in the incorporation of radioactive DNA precursors [5] have all been applied to assess cellular damage after exposure to cytostatic agents. Positive correlations between the results of assays in vitro and the results of clinical chemotherapy in humans have been reported in these studies.
Firefly bioluminescence offers a rapid and specific method for determination of the ATP concentrations in cells [6] . Since intracellular levels of ATP represent the energetic status and the metabolic activity of cells [7, 81 , general cellular activity and cell death can be assessed by means of bioluminescence.
The purposes of the present study were: (1) to determine the ATP content of acute leukaemia and chronic lymphocytic leukaemia cells; (2) to study the changes in the ATP content of leukaemic cells exposed to chemotherapeutic agents and derive dose-response curves; (3) to examine whether intracellular ATP levels and number of viable cells, as determined by the trypan blue dye exclusion test, are correlated; (4) to compare the results of this test in vitro with the response in vivo to chemotherapy.
Materials and methods

Patients
Twenty patients with acute leukaemia (15 with acute myelocytic leukaemia, five with acute lymphocytic leukaemia and nine with chronic lymphocytic leukaemia) were studied. One patient (patient 17 in Table 2 ) was studied when he relapsed after induc-tion chemotherapy for acute lymphocytic leukaemia [9] . All other patients had newly diagnosed leukaemia and had not received prior chemotherapy.
Cytostatics
The following cytostatics were used: adriamycin (Adriblastin, Farmitalia-Carlo Erba, Freiburg, FRG), cytosine arabinoside (Alexan, Mack, Illerh e n , FRG), 4-hydroperoxycyclophosphamide (we thank Dr V. Lierter from Asta, Brackwede, FRG, for providing this substance, which is a derivative of cyclophosphamide active in vitro), vincristine (Oncovin, Eli-Lilly, Giessen, FRG), vinblastine (Velbe, Eli-Lilly, Giessen, FRG), prednisolone (Prednisolon, Chemie Linz, Linz, Austria), 6-mercaptopurine (Sigma Chemical Co., St Louis, MO, U.S.A.), methotrexate (Methotrexat, Cyanamid, Wolfratshausen, FRG), dacarbazine (DTIC, Miles, Stoke Poges, U.K.), 5-fluorouracil (Fluoro-Uracil, Hoffmann-La Roche, Basel, Switzerland), bleomycin (Bleomycin, Lundbeck, Kopenhagen, Denmark), cis-platinum (Platinol, Bristol-Myers, Madrid, Spain), procarbazine (Natulan, Hoffmann-La Roche, Basel, Switzerland), daunomycin (Daunoblastin, Farmitalia-Carlo Erba, Freiburg, FRG) and amsacrin (AMSA-C 1-880, Parke-Davis and Co., Munchen, FRG).
Procedure
Leukaemic blasts were separated from venous blood and bone marrow aspirates by the method of B0yum [ 101 immediately after collection. All experiments in vitro were carried out in medium RPMI 1640 (RPMI 1640 with 2.0 gA sodium bicarbonate without glutamine, Flow Laboratories, Irvine, U.K.) containing 2 mmoVl glutamine (L-glutamine, Flow Laboratories, U.K.), 10% foetal bovine serum (heatinactivated foetal bovine serum, Flow Laboratories, Irvine, U.K.) and 100 pg/ml gentamicin (gentamicin sulphate, equivalent to 50 mg of gentamicidml, Schering, Kenilworth, NJ, U.S.A.). Sterile plastic or siliconized glassware was used in all procedures. The cell count was adjusted to 0.5 x lo6 cells/ml in a Burker counting chamber. The leukaemic cells were distributed into test tubes; cytostatic agents were dissolved in medium and, after preincubation at 37°C for 15 min, were added to the cell suspensions to give the final drug concentrations shown in Table 1 . In drug concentration studies the cytostatic agents were diluted up to 1:50 in culture medium and added to the cell suspensions as described above. In some experiments cells were incubated with cytostatic agents for 60 min at 37"C, washed three times with drug-free medium, resuspended in fresh medium and cultured at 37°C as described above. Cells were held under tissue culturing conditions (5% CO, atmosphere humidified incubator at 37"C), and then ATP was determined in the specimens and in drug-free control incubations after various incubation times. Each value represents the mean of triplicate determinations on one sample from one incubation. 
A TP estimation
Trypan blue test
The trypan blue dye exclusion test was used to estimate cell death after exposure to cytotoxic drugs. Cells were incubated for 4 min with 0.167% (w/v) trypan blue in 0.9% NaCl solution. Cell suspensions were examined under a bright field microscope, and at least 100 cells were counted for each experimental value recorded. Viable cells were identified by their ability to exclude dye; non-viable cells were stained by the dye.
Results
ATP content of leukaemic cells
Immediately after separation of leukaemic cells from peripheral venous blood the intracellular ATP concentrations were determined. Higher ATP levels were measured in leucocytes from patients with acute leukaemia [0.631 fmol f 0.315 (SD) fmol/cell] than in leucocytes from patients with chronic lymphocytic leukaemia [0.435 fmol f 0.214 (SD) fmol/cell], but the difference was not statistically significant.
Influence of cytostatics on ATP concentrations of leukaemic cells
The effect of various cytostatic agents on the intracellular ATP content of leukaemic cells from one patient with acute myelocytic leukaemia is demonstrated in Fig. 1 . A clear fall in intracellular ATP was observed after an incubation period of 2-4 days, when adriamycin (6.6 ,ug/ml of cell suspension), 4-hydroperoxycyclophosphamide (33.3 ,ug/ml), cytosine arabinoside (50 pg/ml) or vinblastine (0.83 ,ug/ml) were added to the cell suspension. Continuous incubation with methotrexate (0.33 ,ug/ml) or 6-mercaptopurine (13.3 pg/ml) produced almost no effect on the ATP content of the leukaemic cells compared with those in the drug-free control incubation. Changes in ATP concentrations of control (drug-free) incubations from patients with acute leukaemia and chronic lymphocytic leukaemia are shown in Fig. 2 .
Intracellular ATP concentrations (ATP content/ cell) were found to be constant throughout the culture period. The influence of various cytostatics on intracellular ATP concentrations of acute leukaemia and chronic lymphocytic leukaemia cells (percentage of control) after a 48 h incubation period is demonstrated in Fig. 3 with adriamycin, 4-hydroperoxycyclophosphamide, vincristine and cytosine arabinoside (Fig. 4) , and with vinblastine, daunomycin and amsacnn. Dose-response curves of drugs having no effect in most experiments even in the highest concentrations listed in Table 1 are not shown (prednisolone, 6-mercaptopurine, methotrexate, dacarbazine, 5-fluorouracil, bleomycin, cis-platinum, procarbazine). The data in Fig. 5 show that the effects of cytostatic drugs on intracellular ATP concentrations in leukaemic cells from patients with acute leukaemia were very similar when the cells were 
Influence of incubation time
Comparison of continuous incubation of acute myelocytic leukaemia cells with adriamycin, amsacrin, daunomycin and cytosine arabinoside with a 1 h incubation with the cytostatic agents followed by prolonged incubation in drug-free culture medium is shown in Fig. 6 . A clear fall in intracellular ATP was seen in both incubation modes when adriamycin, amsacrin or daunomycin were added to the cell suspension. In contrast, while continuous incubation with cytosine arabinoside showed a clear cytotoxic effect on the acute myelocytic leukaemia cells, only a slight fall in intracellular ATP was observed after a 1 h incubation with this cytostatic agent.
Determination of cell viability by the trypan blue dye exclusion test
After various incubation times ATP levels of leukaemic cells and cell viability were determined. A Table 1 . The cystostatic agents remained in the test tubes either throughout the whole culture period ( -) or the cells were washed with fresh medium after a 60 min incubation with cytostatic agents, resuspended and cultured in drug-free medium (----). Fig. 7) . However, the fall in intracellular ATP levels occurred 6-25 h earlier than cell kill as indicated by the dye exclusion test.
Clinical response and results in vitro
Retrospective correlations of the bioluminescence assay results in vitro and the clinical response patterns after treatment are summarized in Table 2 . In two out of 15 acute myelocytic leukaemia patients evaluation of chemotherapy could not be performed (one patient died before onset of therapy, one patient died 4 days after initiation of chemotherapy). Four patients with chronic lymphocytic leukaemia received no treatment, and one patient with chronic lymphocytic leukaemia received trophosfamide therapy (not tested in vitro); these patients are not included in Table 2 .
Fourteen patients with acute leukaemia responded to chemotherapy; three patients were resistant to therapy. One patient (patient no. 1 in Table 2 ) was resistant to the first chemotherapy regimen but responded after change of therapy. In chronic lymphocytic leukaemia three out of four patients responded to therapy. If in the test system in vitro the arbitrary cut-off for 'sensitive' and 'resistant' is set at 70% and 30% respectively compared Table 1 ; continuous drug incubation. S , Sensitive (post-therapy aplasia, leucocyte count below lOOO/pl); R, resistant (failure of a course of therapy to produce aplasia). Results in vitro of cytostatic agents are listed, if the drug used in the treatment of the patient was also tested in vitro. Drugs tested in vitro but not used in the therapy regimen are not shown. Abbreviations: ALL, acute lymphocytic leukaemia; AML, acute myelocytic leukaemia; CLL, chronic lymphocytic leukaemia. Drug abbreviations as in Table 1 with the control incubation, in all patients except patients nos. 15 and 20 in Table 2 , who showed sensitivity to chemotherapy in vivo, a decrease of ATP below 30% compared with the control incubation with at least one drug tested in vitro and applied in vivo was measured. In all five patients resistant in vivo little loss of ATP was observed during the test in vitro with levels of more than 70% of control levels.
Discussion
Various test systems in vitro for the prediction of anti-cancer drug effects have already been published. Evaluation of the degree of cell kill induced by drug treatment is determined either morphologically [ l , 41 or biochemically by measuring incorporation of radioactive DNA precursors into nucleic acids and correlating inhibition of DNA synthesis with cell death [5, 111 . Dye exclusion assays have also been used as a basis for quantifying cell death in vitro [2, 31. Comparison of a novel fast green dye exclusion assay with a clonogenic assay showed that the standard agar cloning assay gave somewhat higher estimates of cell kill than the dye exclusion method, but both assays were in qualitative agreement for the drugs tested [12] . However, agar cloning assays are time consuming and technical disadvantages limit their application in preclinical drug screening [ 131.
The test described in this paper measures the effects of cytostatic agents on the intracellular ATP content of leukaemic cells. A good correlation (0.819) was found between the ATP content of the cell suspensions and the percentage of viable cells as determined by the trypan blue dye exclusion assay after various incubation periods. However, cell kill was indicated by the fall in intracellular ATP levels between 6 and 25 h earlier than it could be determined by the dye exclusion test.
The bioluminescence assay demonstrated a clear dose-effect relationship for most of the drugs tested. The drug sensitivity spectrum vaned from patient to patient, but there remained some general relationships among good, better and the best drugs. For example, adriamycin and cytosine arabinoside showed a strong effect, whereas bleomycin and cis-platinum showed almost no effect on the leukaemic cells.
When compared with other assays, determination of intracellular ATP using bioluminescence as indicator of drug induced cytotoxicity may have certain unique advantages. (1) Visual cell count in a large number of samples is time consuming. Determination of ATP in a sample using bioluminescence requires only 20 s. Therefore, the simple and rapid determination of ATP enables us to assay a single cell line repeatedly on several days. (2) The sensitivity of the bioluminescence assay for ATP is high enough to measure mol of ATP in a sample [14] . In order to assay 10 drugs at a single concentration (plus one control), a minimum of about 14000 cells is required, which is about 1/40 of the number of cells required for assaying a similar number of drugs using the dye exclusion assay and about 1/400 of that required in the agar cloning assays [3] . ( 3) The bioluminescence assay does not depend upon cell growth in culture, making it possible to assay neoplasms which do not grow in agar. However, the assay requires an optimal single cell suspension, which is easily obtained in acute leukaemia and chronic lymphocytic leukaemia. (4) The cytostatic effect on leukaemic cells was observed within 48 h in most experiments; this short period of culture time may have advantages in a clinical situation.
In most experiments leukaemic cells were incubated continuously with cytostatic agents. No differences in the cytostatic effect were found between a continuous and a 1 h incubation of leukaemic cells with adriamycin, amsacrin and daunomycin. However, an incubation of cytosine arabinoside for 1 h did not seem to be sufficient to indicate cytotoxicity (Fig. 6) . Also in some experiments a delayed decrease in intracellular ATP was observed with cytosine arabinoside. For example, in patient no. 7 (Table 2), 60% ATP was measured compared with the cystostatic-free control incubation after a 48 h incubation time of the acute myelocytic leukaemia cells with cytosine arabinoside; after 72 h 30% ATP was measured indicating sensitivity to cytosine arabinoside.
Since most patients were treated by drug combinations and not with single cytostatic agents it was difficult to establish correlations in vitro and in vivo. Therefore, individual clinical correlations are of a preliminary nature. However, the assay data suggest a correlation between the chemosensitivity in vitro and the response patterns in leukaemia patients in vivo. At least one drug included in the chemotherapy regimen of the responding patients showed a decrease in ATP below 30% compared with control in the test system in vitro, thus indicating sensitivity. Patient no. 15 (Table 2 ) received a polychemotherapy [9] , including other drugs not tested in vitro (daunomycin, cyclophosphamide, methotrexate, L-asparaginase); patient no. 20 (Table  2) received additionally chlorambucil (not tested in vitro). Therefore, correlation of results in vivo and in vitro is of limited value in these two patients. It is noteworthy that all five patients resistant to chemotherapy showed > 70% of control ATP after a 48 h incubation in the test system in vitro, indicating resistance to the drugs. Patient no. 1 ( Table 2) , resis-tant to vincristine in vitro, was also resistant to vincristine therapy in vivo. After change of therapy to a cytosine arabinoside-containing protocol, the sensitivity to cytosine arabinoside predicted in vitro was observed also in vivo.
Application of the bioluminescence assay may have a useful role in chemosensitivity testing in vitro. Another potential application might be as a test in vitro to identify new antineoplastic agents. However, further work will be required to determine accuracy and limitations of the assay.
